Real-world data on rufinamide treatment in patients with Lennox –Gastaut syndrome: Results from a European noninterventional registry study

Conclusion The study provided valuable information on LGS and its management, and evidence that rufinamide has a consistent and generally favorable safety/tolerability profile when used in routine clinical practice. ClinicalTrials.Gov identifier NCT01991041
Source: Epilepsy and Behavior - Category: Neurology Source Type: research